Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

ISSN： 2213-476X

Source： Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.2, Iss.2, 2015-08, pp. : 60-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosuvastatin safety: lessons from the FDA review and post-approval surveillance

By Davidson Michael H

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 547-557

Informa Healthcare

Access to resources Recommend Favorite

A liposomal amphotericin B injection [Amphocil; Samaritan Pharmaceuticals Europe] has received approval in Cyprus, for invasive aspergillosis

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval

By Giezen Thijs J. Mantel-Teeuwisse Aukje K. Straus Sabine M.J.M.

Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. : 1175-1187

Adis International

Access to resources Recommend Favorite

Is the Large Simple Trial Design Used for Comparative, Post-Approval Safety Research?: A Review of a Clinical Trials Registry and the Published Literature

By Reynolds Robert F. Lem Joanna A.

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 799-820

Adis International

Access to resources Recommend Favorite

By Nick Cecil

Pharmaceutical Medicine, Vol. 26, Iss. 3, 2012-06 ,pp. : 145-152

Adis International

Access to resources Recommend Favorite